These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 19494665)
1. Disorders of phosphate homeostasis and tissue mineralisation. Bergwitz C; Jüppner H Endocr Dev; 2009; 16():133-56. PubMed ID: 19494665 [TBL] [Abstract][Full Text] [Related]
2. FGF23 and syndromes of abnormal renal phosphate handling. Bergwitz C; Jüppner H Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161 [TBL] [Abstract][Full Text] [Related]
3. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Bergwitz C; Jüppner H Annu Rev Med; 2010; 61():91-104. PubMed ID: 20059333 [TBL] [Abstract][Full Text] [Related]
4. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Razzaque MS Nat Rev Endocrinol; 2009 Nov; 5(11):611-9. PubMed ID: 19844248 [TBL] [Abstract][Full Text] [Related]
5. [Discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis]. Nabeshima Y Clin Calcium; 2008 Jul; 18(7):923-34. PubMed ID: 18591743 [TBL] [Abstract][Full Text] [Related]
7. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules. Ide N; Ye R; Courbebaisse M; Olauson H; Densmore MJ; Larsson TE; Hanai JI; Lanske B Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1261-F1270. PubMed ID: 29993278 [TBL] [Abstract][Full Text] [Related]
8. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Liu S; Gupta A; Quarles LD Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275 [TBL] [Abstract][Full Text] [Related]
9. Klotho gene, phosphocalcic metabolism, and survival in dialysis. Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771 [TBL] [Abstract][Full Text] [Related]
11. Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Bacchetta J; Bardet C; Prié D Metabolism; 2020 Feb; 103S():153865. PubMed ID: 30664852 [TBL] [Abstract][Full Text] [Related]
12. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Stubbs J; Liu S; Quarles LD Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819 [TBL] [Abstract][Full Text] [Related]
13. Contribution of Bone Tissue to Regulation of Calcium and Phosphate Metabolism. Role of FGF23 and Klotho Protein. Brzęczek M; Hyla-Klekot L; Kokot F; Synder M Ortop Traumatol Rehabil; 2020 Apr; 22(2):69-76. PubMed ID: 32468993 [TBL] [Abstract][Full Text] [Related]
14. FGF23 and Bone and Mineral Metabolism. Fukumoto S Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685 [TBL] [Abstract][Full Text] [Related]
15. [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control]. Prié D; Ureña Torres P; Friedlander G Med Sci (Paris); 2009 May; 25(5):489-95. PubMed ID: 19480830 [TBL] [Abstract][Full Text] [Related]
16. A potential link between phosphate and aging--lessons from Klotho-deficient mice. Kuro-o M Mech Ageing Dev; 2010 Apr; 131(4):270-5. PubMed ID: 20197072 [TBL] [Abstract][Full Text] [Related]
17. FGF23 and Phosphate Wasting Disorders. Huang X; Jiang Y; Xia W Bone Res; 2013 Jun; 1(2):120-32. PubMed ID: 26273497 [TBL] [Abstract][Full Text] [Related]
18. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Quarles LD Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601 [TBL] [Abstract][Full Text] [Related]
19. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis. Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. Nakatani T; Ohnishi M; Razzaque MS FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]